Literature DB >> 18409149

Coagulation factor levels in non-metastatic colorectal cancer patients.

S Battistelli1, M Stefanoni, B Lorenzi, R Dell'avanzato, F Varrone, A Pascucci, R Petrioli, A Vittoria.   

Abstract

UNLABELLED: There is evidence that high plasma levels of factor (F) VIII, FIX, FXI and fibrinogen are independent risk factors for venous thromboembolism. AIM: To determine the plasma concentrations of several coagulation factors and C4b-binding protein (C4BP) in a group of patients with non-metastatic colorectal cancer in order to investigate some aspects of cancer-acquired thrombophilia.
METHODS: Plasma fibrinogen, FII, FV, FVII, FVIII, FIX, FX, FXI and FXII activity levels and C4BP concentrations were determined in 73 patients with non-metastatic colorectal cancer (48 colon and 25 rectum) and in 67 matched control subjects. No one in either group had had previous thrombotic events.
RESULTS: Mean plasma concentrations of fibrinogen (functional and antigen), FVIII, FIX, FV and C4BP were significantly higher in colorectal cancer patients than in control subjects, while FVII and FXII levels were significantly decreased. Several correlations were found between the increased coagulation factors and C4BP concentrations, while FVII was highly correlated with FXII.
CONCLUSIONS: In colorectal cancer patients high plasma fibrinogen, FVIII and FIX levels might represent further risk factors for venous thrombotic complications in the immediate post-surgery period, while decreased FVII and FXII concentrations may be an index of intravascular coagulation activation, still in a subclinical phase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18409149

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   2.659


  8 in total

1.  Acquired factor VII deficiency following FOLFOX in a patient with colorectal cancer who was also DPD deficient.

Authors:  Muhammad Wasif Saif; Komal Wasif; Harriette Butler-Bowen; Kenneth Miller; Robert B Diasio
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

2.  The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis.

Authors:  Katrin F Nickel; Göran Ronquist; Florian Langer; Linda Labberton; Tobias A Fuchs; Carsten Bokemeyer; Guido Sauter; Markus Graefen; Nigel Mackman; Evi X Stavrou; Gunnar Ronquist; Thomas Renné
Journal:  Blood       Date:  2015-07-07       Impact factor: 22.113

Review 3.  Mechanisms and biomarkers of cancer-associated thrombosis.

Authors:  Ann S Kim; Alok A Khorana; Keith R McCrae
Journal:  Transl Res       Date:  2020-07-06       Impact factor: 7.012

4.  Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract.

Authors:  Remond J A Fijneman; Rebecca A Anderson; Ethan Richards; Jieming Liu; Marianne Tijssen; Gerrit A Meijer; Janae Anderson; Annette Rod; Michael G O'Sullivan; Patricia M Scott; Robert T Cormier
Journal:  Cancer Sci       Date:  2012-01-19       Impact factor: 6.716

Review 5.  Cancer-associated venous thromboembolism.

Authors:  Alok A Khorana; Nigel Mackman; Anna Falanga; Ingrid Pabinger; Simon Noble; Walter Ageno; Florian Moik; Agnes Y Y Lee
Journal:  Nat Rev Dis Primers       Date:  2022-02-17       Impact factor: 65.038

Review 6.  Biomolecular markers of cancer-associated thromboembolism.

Authors:  Diana L Hanna; Richard H White; Ted Wun
Journal:  Crit Rev Oncol Hematol       Date:  2013-03-21       Impact factor: 6.312

7.  Coagulative safety of epidural catheters after major upper gastrointestinal surgery: advanced and routine coagulation analysis in 38 patients.

Authors:  Owain Thomas; Hampus Rein; Karin Strandberg; Ulf Schött
Journal:  Perioper Med (Lond)       Date:  2016-10-18

8.  Proteomic profiling of urine for the detection of colon cancer.

Authors:  Douglas G Ward; Stephen Nyangoma; Howard Joy; Emma Hamilton; Wenbin Wei; Chris Tselepis; Neil Steven; Michael J O Wakelam; Philip J Johnson; Tariq Ismail; Ashley Martin
Journal:  Proteome Sci       Date:  2008-06-16       Impact factor: 2.480

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.